Trials / Completed
CompletedNCT01749410
A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 33 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the effectiveness and benefit of treatment with onabotulinumtoxinA in Chronic Migraine patients who have received a minimum of 7 treatment cycles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | onabotulinumtoxinA | Previous treatment with onabotulinumtoxinA for Chronic Migraine. |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2012-12-13
- Last updated
- 2015-09-10
- Results posted
- 2015-09-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01749410. Inclusion in this directory is not an endorsement.